Skip to content
March 27, 2024

Equity.Guru

Investment information for the new generation

Search

Qixleef

Closing the Diabetic Loop Before we get into this week’s sector roundup, let’s talk about diabetes. I am a sucker for sweets, so much so that I was diagnosed…
Tetra Bio-Pharma (TBP.T) (“Tetra”) is a biopharmaceutical company focused on cannabinoid-derived drug discovery and development. The Company has an FDA and Health Canada cleared clinical program intended to bring…
[image credit: https://weedit.network/] The overall health of the cannabis sector still isn’t good. Think crypto and blockchain in the winter of 2018 and you get an idea of what…
Tetra Bio-Pharma (TBP.T) announced they are accelerating their PLENITUDE Phase II clinical trial, which is studying QIXLEEF. QIXLEEF is Tetra’s proprietary drug formulation which contains THC and CBD and…
Tetra Bio-Pharma (TBP.T) has shipped Qixleef, its investigational new drug, to the United States for initiation of the REBORN1 study. The REBORN1 study will investigate cannabis as an alternative…
It’s time for your Tuesday cannabis rundown. First up: The Green Organic Dutchman Holdings (TGOD.T) signed a letter of intent with the Societe quebecoise du cannabis (SQDC) before its…
Tetra Biopharma (TBP.V) has been busy conducting clinical development programs of two potential products, the first being Quixleef and the second Plenitude. Both involve dealing with uncontrolled pain in…